Genentech---DNAFrom the China Analyst. I really like The China Analyst Website. It always provides up to date and accurate reports and top ten lists of top performers week in and week out. China Analyst has Talecris as No. 3 as stocks that have provided Return On Equity. It is a pretty good indication of how profitable a company is and how well the business is working. Basically a good return on equity means their stock will more than likely be going up. I also look for Undervalued Companies with a High ROE and a Low P/E. A Low Price/Earnings means that the company is undervalued. I high P/E means that a company is overvalued. Overvalued companies tend to have a bubble affect and when that bubble bursts it can be a loss on investments. Therefore a low P/E is a good investment, if the company is profitable.
In this case I chose Skystar Biopharmaceuticals as my investment of today. Skystar is symbol (SKBI). Skystar is the maker of Animal Vaccinations in China. Skystar is highly profitable and has the GMP facilities to make enough vaccines.
Remember America's Chicken Egg Fiasco a couple of months ago from an Iowa Chicken Factory. Skystar makes Chicken Vaccines and is rapidly growing. Take the time to look at Skystar's Financial Records and see how well the company is doing. Again that is Skystar Biopharmaceuticals SKBI They are a Chinese Company trading on the Nasdaq.
If you would like more Subscribe To BioPharma Investor for everyday stock news and up to date FDA decisions. Biopharma Investor
Wikinvest---SKBI
More can be found at their website: Skystar Bio-Pharm
Here is an article from Seeking Alpha which highlights Skystar's Business Model from 2007. The stock has been performing well since then.
Skystar Bio Pharma: Leading Contender in Rapidly Growing Chinese Biopharma Market
Top 10 Biotech Stocks with Highest Return on Equity: IMMU, CRME, TLCR, GILD, GTXI, PSDV, SKBI, DNA, CPHI, SCLN (Oct 12, 2010)
Best-Rated Chinese Stocks; Highest-Upside; Fastest-Growing; Top 10 Lists; Analyst Actions
Below are the top 10 Biotechnology stocks with highest Return on Equity (ROE) ratio for the last 12 months, UPDATED TODAY before 4:30 AM ET. ROE shows a company's efficiency in making profits from shareholders' equity. It is equal to net profits divided by shareholders' equity. Two Chinese companies (SKBI, CPHI) are on the list.
1. Immunomedics, Inc. (NASDAQ:IMMU) has the 1st highest Return on Equity in this segment of the market. Its ROE was 173.30% for the last 12 months. Its net profit margin was 60.72% for the same period.
2. CARDIOME PHARMA CORP (NASDAQ:CRME) has the 2nd highest Return on Equity in this segment of the market. Its ROE was 143.65% for the last 12 months. Its net profit margin was 40.02% for the same period.
3. Talecris Biotherapeutics Holdings Corp (NASDAQ:TLCR) has the 3rd highest Return on Equity in this segment of the market. Its ROE was 101.84% for the last 12 months. Its net profit margin was 17.85% for the same period.
4. Gilead Sciences, Inc. (NASDAQ:GILD) has the 4th highest Return on Equity in this segment of the market. Its ROE was 51.77% for the last 12 months. Its net profit margin was 38.63% for the same period.
5. GTx, Inc. (NASDAQ:GTXI) has the 5th highest Return on Equity in this segment of the market. Its ROE was 41.48% for the last 12 months. Its net profit margin was 11.89% for the same period.
6. pSivida Corp. (NASDAQ:PSDV) has the 6th highest Return on Equity in this segment of the market. Its ROE was 30.94% for the last 12 months. Its net profit margin was 37.97% for the same period.
7. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) has the 7th highest Return on Equity in this segment of the market. Its ROE was 26.77% for the last 12 months. Its net profit margin was 30.88% for the same period.
8. Genentech, Inc. (NYSE:DNA) has the 8th highest Return on Equity in this segment of the market. Its ROE was 24.85% for the last 12 months. Its net profit margin was 25.54% for the same period.
9. China Pharma Holdings, Inc. (AMEX:CPHI) has the 9th highest Return on Equity in this segment of the market. Its ROE was 24.12% for the last 12 months. Its net profit margin was 32.68% for the same period.
10. SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) has the 10th highest Return on Equity in this segment of the market. Its ROE was 23.96% for the last 12 months. Its net profit margin was 19.16% for the same period
Related articles
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.